- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07195019
- Original Trial
Women's Wellbeing Study
Treatments for Improving Mood in Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In Phase 2, the investigators will conduct a pilot randomized controlled trial (RCT) of 12 weeks of integrative yoga and mindful self-compassion training (I-YMSC) vs. 12 weeks of women's wellbeing education (WWE).
Participants will be women with a history of interpersonal violence exposure and heightened distress.
Participants will be randomized to Phase 2 groups of 12 weeks of I-YMSC or WWE. Forty-eight women will be enrolled.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Recruiting
- Butler Hospital
-
Contact:
- Research Coordinator
- Phone Number: 401-455-6200, ext. 21070
- Email: i-ymsc.study@butler.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- Ages 18-65
- Report having experienced interpersonal violence (defined to include all forms throughout the lifespan, confirmed with the Trauma History Questionnaire (THQ])
- Report being distressed, defined by a score of >5 on the Kessler-6 screener
- Speak and understand English well enough to understand questionnaires when they are read aloud
- Have access to a telephone through owning one, a relative/friend, or an agency
- Have access to a device that will support use of the video platform we are using to conduct assessments and for home practice yoga video sessions
Exclusion Criteria:
- Inability to be physically active, determined by a score >1 on the Physical Activity Readiness Questionnaire (PAR-Q) and physician non-consent of participation
- Planned surgery in next 6 months, as this would interfere with study participation
Pregnancy, as yoga should be modified for pregnancy
Women who meet criteria for the following:
- Current mania as determined by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)
- Lifetime history of psychotic disorders (DIAMOND)
- Current probable severe substance use disorder (DIAMOND)
- Current diagnosis of anorexia nervosa or history in past year (DIAMOND)
- Moderate or high risk for suicide on the adapted Columbia Suicide Severity Rating Scale screen version-recent (C-SSRS) and/or endorsement of suicidal plan/intent in the past 3 months
- Non-stable course of psychiatric treatments (medication, psychotherapy) for the last 8 weeks
- Plan to move from the area in the next 6 months, as this may preclude study participation given enrollment timeframes
- Self-report of experiencing intimate partner violence currently or within past six months (assessed by the Revised Conflict Tactics Scale 2 [R-CTS2]), as this would require a different type of intervention
- Current weekly yoga practice or current participation in mindfulness-based programming, as these are the study interventions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Integrative Yoga and Mindful Self-Compassion (I-YMSC) training
12 weeks of I-YMSC training
|
Group Integrative Yoga & Mindful Self-Compassion training for women with a history of interpersonal violence exposure and distress
|
|
Active Comparator: Women's Wellbeing Education (WWE)
12 weeks of group WWE
|
Group women's wellbeing education for women with a history of interpersonal violence exposure and distress
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Post intervention (month 3)
|
Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8).
The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32.
Higher scores indicate greater client satisfaction.
|
Post intervention (month 3)
|
|
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)
Time Frame: Post intervention (month 3)
|
Participant safety/adverse events will be measured using the SAFTEE.
Participants will also be asked weekly if they experienced any injuries as a result of yoga.
|
Post intervention (month 3)
|
|
Feasibility
Time Frame: Post intervention (month 3)
|
Feasibility assessed based on number of participants who remained in the intervention (retention).
|
Post intervention (month 3)
|
|
Feasibility of Intervention Measure
Time Frame: Post intervention (month 3)
|
The Feasibility of Intervention Measure (FIM) construct comprises four items with each item measured on a 1-5 scale.
The total score range is from 4-20.
Higher scores indicate greater feasibility.
|
Post intervention (month 3)
|
|
Intervention Appropriateness Measure
Time Frame: Post intervention (month 3)
|
The Intervention Appropriateness Measure (IAM) construct comprises four items with each item measured on a 1-5 scale.
The total score range is from 4-20.
Higher scores indicate greater feasibility.
|
Post intervention (month 3)
|
|
Acceptability of Intervention Measure
Time Frame: Post intervention (month 3)
|
The Acceptability of Intervention Measure (AIM) comprises four items with each item measured on a 1-5 scale.
The total score range is from 4-20.
Higher scores indicate greater feasibility.
|
Post intervention (month 3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Anxiety and Stress Scale (DASS-21)
Time Frame: Baseline to post intervention (month 3)
|
Distress at Month 3. The DASS-21 is a 21-item measure with each item measured on a 0-3 scale, and total score conversion ranging from 0-63.
Higher global scores indicate greater psychological distress.
|
Baseline to post intervention (month 3)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1871144-2
- K23AT011917 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.